NCATS-supported scientists are engaged in cutting-edge translational research activities across the United States. Read the latest news about CTSA Program researchers that are collaborating locally, regionally and nationally, fostering innovation in training and methodologies to get more treatments to more patients more quickly.
Learn more about the CTSA Program in Action:
- Goal 1: Train and Cultivate the Translational Science Workforce
- Goal 2: Engage Patients and Communities in Every Phase of the Translational Process
- Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan
- Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials
- Goal 5: Advance the Use of Cutting-Edge Informatics
NCATS and Eli Lilly partnered on the NCATS-Eli Lilly scholars externship program, which pairs scholars, trainees and investigators from NCATS’ CTSA Program with an Eli Lilly project team for up to one year.
- CTSA Program Mentoring Paves Way for Brain Cancer Therapy
- CTSA Program Support Helps Talented Investigators Re-Establish Careers
- From ER Physician to Translational Scientist via CTSA Program Support
CTSA Program representatives collaborated with patient advocacy groups to host four national meetings promoting public engagement in the Notice of Proposed Rulemaking (NPRM) on the Federal Policy for the Protection of Human Subjects.
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research across the Human Lifespan
Efforts are now underway to add rare diseases to newborn screenings through Early Check, a research program in which voluntary screening for fragile X syndrome and other genetic conditions yet to be determined will be offered to up to 120,000 families each year in North Carolina. NCATS is supporting Early Check through a CTSA Program Collaborative Innovation Award (CCIA).
- Unprecedented Trans-NCATS Collaboration Enables Rapid Advancement of Rare Lung Disease Therapy to Human Trials
- CTSA Program-Supported Research Uncovers Genetic Components of Healthy Aging
- CTSA Program Supports Research Network in Geographically Isolated Region
Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials
Through NCATS’ new Trial Innovation Network, CTSA Program-supported investigators are working collaboratively to tackle inefficiencies in clinical trials.
- NCATS SMART IRB Platform Agreement
- North Carolina CTSA Program Hubs Create Regulatory Expertise Platform
- CTSA Program Good Clinical Practice Standards Published
A team of CTSA researchers are developing and evaluating a suite of software tools that will allow all CTSA Program sites to integrate PROMIS tools directly into their electronic health records.
- NCATS-Supported Researchers Recruit Citizen Scientists to Help Mine Biomedical Literature
- CTSA Program Domain Task Forces: Spotlight on Informatics
- Improving Patient Recruitment: The Accrual to Clinical Trials Initiative